This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The upcoming MedicarePrescription Payment Plan (M3P), set to launch in January 2025, marks a significant shift in Medicare’s approach to prescriptiondrug coverage. Price Transparency: Increased transparency in drugpricing to enable beneficiaries to make informed decisions.
A snowy first week of January gave us plenty of time to read some of the last research from 2024. This month we read about prescriptiondrugpricing and the impacts of rebates on consumers, as well as market shares of Medicare Advantage carriers.
While the digital health stakeholder community is convening this week at VIVE in Los Angeles to share innovations in health tech, NABIP has assembled health insurance leaders in Washington, DC, for the 2024 Capital Conference to focus on major health reform issues that are top-of-mind for health care payors — which in today’s U.S.
To advance these efforts, CMS established a MedicareDrug Rebate and Negotiations Group dedicated to the IRA and set forth the agency’s intended overarching timeline to implement the various IRA provisions, such as the MedicareDrugPrice Negotiation Program and the Part D redesign.
The upcoming MedicarePrescription Payment Plan (M3P), set to launch in January 2025, marks a significant shift in Medicare’s approach to prescriptiondrug coverage. Price Transparency: Increased transparency in drugpricing to enable beneficiaries to make informed decisions.
The Rebate Programs are administered as part of the prescriptiondrug affordability provisions of the Inflation Reduction Act (the “IRA”), which is aimed at “lower[ing] out-of-pocket drug costs for people with Medicare and improv[ing] the sustainability of the Medicare program for current and future generations.” [1]
Bureau of Labor Statistics had good news for American consumers long-facing inflation for household spending over the past couple of years, announcing on July 11, 2024, that the general consumer price index (CPI) fell, lowering real prices for people buying airline tickets, used cars and trucks, communication, and petrol to fill auto tanks.
Add into this picture a CCS Insight analyst’s forecast last week that Apple could enter the health insurance market in 2024. health care system not seen since the 1968 creation of Medicare, coupled with decreased reimbursement due to health care reform. Walmart) to do so, as well.
1339) reflects the overarching legislative push by members from both sides of the aisle and chambers of Congress to address drugpricing issues through federal fixes to the PBM framework. Unlike the IRA, which targeted the Medicare program, the provisions of S. 1339, adding several new amendments to create the version of S.
First, it would give the federal government the ability to negotiate prices of some drugs purchased by Medicare beneficiaries, a tool that has long been opposed by the drug industry. Never before have we been able to negotiate prescriptiondrugprices. Those prices would take effect in 2026.
Economy Inflation, a top-of-mind stress and concern for mainstream Americans in 2023, is easing as we enter 2024. At this moment, the price of gas at the pump was playing a big role in U.S. entering 2024, many consumers will be self-rationing care due to costs. Consumer in the Big/Macro U.S. Another positive aspect of the U.S.
A close second in line is affordability of health care, as consumers’ household budgets must make room for paying medical bills — with prescriptiondrug costs also very important as a discussion topic for 2024 Presidential candidates, we learn from the latest KFF Health Tracking Poll published 1 December.
with about 60 days leading up to the 2024 Elections, we might assume there are no “purple” areas of agreement between the Red (Republicans) and the Blue (Democrats) thinking in PANTONE color politics. In a super-divided electorate like the U.S. adults in May 2004.
Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ million expansion ‘Very, very unusual.’
Moore’s 2024 budget MASSACHUSETTS Cancer drugmaker down to 3 employees after trial failure Fallon Health CEO to retire after 25 years with Worcester-based health plan FEMA provides $4M to Massachusetts for daycare Covid-19 testing costs Massachusetts hospital to remain closed for 3 months after fire Nurses keep protesting staffing shortages.
of Maryland medical school opens addiction research institute in Baltimore MedStar Health breaks even in Q1 as revenues near $2B MASSACHUSETTS Boston Hospital Pays $5.7
NATIONAL 5 Stark law issues physicians are closely watching Anti-monopoly advocates urge FTC to block McKesson, Cardinal Health’s big-ticket oncology acquisitions Biden administration doles out $68.5M to resolve fraudulent lab testing allegations Lilly to invest another $4.5B to make breast cancer treatments safer St.
in Medicare fraud settlement 10 behavioral health policy changes taking effect in 2025 An uncertain era for Stark law: 12 updates in 2024 CMS launches campaign to support nursing home staffing rule CMS taps 4 states for behavioral innovation model: 5 things to know Epic files to dismiss antitrust lawsuit Healthcare company to pay $15.2
New president tapped to lead major hospital system in Denver area New president to lead opening of $650M hospital in Wheat Ridge Telehealth program offers support to forensic nurses Colorado Medicaid program settles lawsuit over lack of mental health care for children Colorado is trying to cut prescriptiondrugprices.
operating margin for 2024, misses 2023 target University of Michigan Health-West forms portal to track DEI among suppliers, vendors S. Maryland AG urges White House to strengthen HIPAA for people getting abortions Westminster startup raising $2.3M
Together, these three current events inter-connect with the passionate intention of including patients in the 2024 voting process in the U.S. Health Populi’s Hot Points: If voting is a driver of health, than each of us has an opportunity to get healthy by getting informed about health policy.
Based on the results of the first-in-the-nation primary in New Hampshire, it appears more likely than ever before that the 2024 presidential election will be a rerun of 2020: Joe Biden versus Donald Trump. And health is shaping up to be a key issue. And subscribe to KFF Health News’ “What the Health?
For health care, there are many uncertainties as we reflect, one week after the 2024 U.S. insured consumers’ perspectives on prescriptiondrugpricing and the role of PBMs (pharmacy benefit managers). Pollfish conducted this study online in October 2024. than anywhere else in the world.
The manufacturer sought to cover Medicare patients’ Part D cost-sharing obligations for the drug – which were estimated at approximately $13,000 per year – but the OIG said “no thanks,” and the Second Circuit has affirmed that outcome. The problem is, as stated before, the drug is expensive; an annual course costs $225,000.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content